Kohler Terry
- SEC CIK
- 0001872285
No open-market purchases or sales filed in the past year.
Current role at each company
- ADMA Adma Biologics, Inc.CFO and Treasureras of Jul 17, 2026
- OPTN OptiNose, Inc.Chief Financial Officeras of May 21, 2025
- VRCA Verrica Pharmaceuticals Inc.CHIEF FINANCIAL OFFICERas of Feb 6, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kohler Terry as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRCA Verrica Pharmaceuticals Inc.
CHIEF FINANCIAL OFFICER2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2024 (view filing) | Aug 26-27 | 2 days | Kohler TerryCHIEF FINANCIAL OFFICER | SSale | −29.7K | $2.61 | −$77.5K | −39.9%44.7K after | 2 lots |
| Nov 16, 2023 (view filing) | Nov 14-15 | 2 days | Kohler TerryChief Financial Officer | SSale | −28.1K | $2.94 | −$82.7K | −44.9%34.4K after | 2 lots |